From the Guidelines
No, tax should not be given after every vaginal birth, as it is likely a misunderstanding and the correct term might be "Tdap" vaccination or another medical intervention. I believe you may be referring to a medical intervention rather than "tax." The provided evidence does not support the administration of "tax" after vaginal birth. According to the study 1, post-partum care involves a slow i.v. infusion of oxytocin to prevent maternal haemorrhage, but it does not mention "tax." The study 1 discusses the effects of labor and childbirth on subsequent pregnancy and the importance of a positive birth experience in preventing medium-term and long-term complications, but it also does not mention "tax." Given the potential for confusion and the lack of evidence supporting the use of "tax" after vaginal birth, it is recommended to prioritize evidence-based medical interventions, such as those outlined in the studies 1 and 1, to ensure the best possible outcomes for mothers and babies in terms of morbidity, mortality, and quality of life. Some key points to consider in post-partum care include:
- The administration of oxytocin to prevent maternal haemorrhage 1
- The importance of a positive birth experience in preventing medium-term and long-term complications 1
- The potential risks and benefits of various medical interventions, such as uterotonics, episiotomy, and instrumental vaginal birth 1
From the FDA Drug Label
To control postpartum bleeding, 10 to 40 units of oxytocin may be added to 1,000 mL of a nonhydrating diluent and run at a rate necessary to control uterine atony Intramuscular Administration – 1 mL (10 units) of oxytocin can be given after delivery of the placenta.
The administration of oxytocin after every vaginal birth is not explicitly stated in the provided drug labels. However, oxytocin can be given to control postpartum bleeding or after delivery of the placenta.
- Key consideration: The decision to administer oxytocin should be based on the individual patient's needs and medical history.
- Administration: Oxytocin can be administered intravenously or intramuscularly, with the dose and route depending on the specific clinical situation.
- Reference: 2
From the Research
Tax After Vaginal Birth
- There is no direct evidence in the provided studies to support the idea of giving tax after every vaginal birth 3, 4, 5, 6, 7.
- The studies focus on the prevention and treatment of postpartum hemorrhage using uterotonic medications such as oxytocin, methylergonovine, carboprost, and misoprostol 3, 4, 5, 6, 7.
- The use of these medications is recommended to prevent postpartum hemorrhage, but there is no mention of tax being given after vaginal birth 3, 4, 5, 6, 7.
Uterotonic Medications
- Oxytocin is the first-line agent for preventing postpartum hemorrhage 3, 4, 6.
- Methylergonovine and carboprost are highly effective second-line agents, but have severe potential side effects 6.
- Misoprostol is a useful therapeutic in resource-limited practice environments, but its effectiveness as an adjunct to other uterotonic agents has been called into question 6.
- The combination of oxytocin and methylergonovine has been shown to reduce the need for additional uterotonic agents and lower the incidence of postpartum hemorrhage 7.
Prevention of Postpartum Hemorrhage
- Combined therapy rather than oxytocin alone is recommended for preventing postpartum hemorrhage 3.
- The use of tranexamic acid has been found to be effective and safe for decreasing maternal mortality in women with postpartum hemorrhage 3, 4.
- Controlled cord traction and delayed cord clamping are also recommended for the prevention of postpartum hemorrhage 4.